Research and Markets: Tropical Disease Partnering 2007-2013

Research and Markets: Tropical Disease Partnering 2007-2013

<0> Research and MarketsLaura Wood, Senior Manager.U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: </0>

() has announced the addition of the report to their offering.

The Tropical Diseases Partnering 2007-2013 provides understanding and access to the tropical diseases partnering deals and agreements entered into by the worlds leading healthcare companies.

This data driven report includes:

In Tropical Diseases Partnering 2007-2013, the available deals are listed by:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in tropical diseases partnering

2.1. Introduction

2.2. Tropical diseases partnering over the years

2.3. Bigpharma tropical diseases dealmaking activity

2.4. Tropical diseases partnering by deal type

2.5. Tropical diseases partnering industry sector

2.6. Tropical diseases partnering by stage of development

2.7. Tropical diseases partnering by technology type

2.8. Disclosed financial deal terms for tropical diseases partnering

2.8.1 Tropical diseases headline values

2.8.2 Tropical diseases upfront payments

2.8.3 Tropical diseases milestone payments

2.8.4 Tropical diseases royalty rates

Chapter 3 - Leading tropical diseases deals

3.1. Introduction

3.2. Top tropical diseases deals by value

3.3. Top tropical diseases deals involving bigpharma

Chapter 4 - Dealmaking directory

4.1. Introduction

4.2. Company A-Z

4.3. By deal type

4.4. By industry sector

4.5. By stage of development

Chapter 5 - Partnering resource center

5.1. Online partnering

5.2. Partnering events

5.3. Further reading on dealmaking


For more information visit

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.